Global Hereditary Testing Market Overview:
Global Hereditary Testing Market Report 2025 provides a comprehensive analysis of the industry, covering key factors such as market trends, growth drivers, developments, size, and dynamics. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Hereditary Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Hereditary Testing Market
The Hereditary Testing Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Hereditary Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting the growth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Hereditary Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Hereditary Testing market has been segmented into:
Hereditary Cancer Testing
Hereditary Non-cancer Testing
By Application, Hereditary Testing market has been segmented into:
Hospital
Clinic
Laboratory
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East and Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Hereditary Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Hereditary Testing market.
Top Key Players Covered in Hereditary Testing market are:
Myriad Genetics Inc.
CooperSurgical Inc.
Natera Inc.
Invitae Corporation
Quest Diagnostics Incorporated
Illumina Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Agilent Technologies Inc.
CENTOGENE
Twist Bioscience
Medgenome
Sophia Genetics
Fulgent Genetic Inc.
Research Methodology:
Our report provides a detailed breakdown of the market, divided into segments like Type and Application, each with its own sub-categories. We also examine major competitors, looking at their market size, share, and recent activities such as mergers, acquisitions, and partnerships. This helps new and existing businesses in the Hereditary Testing Market understand the competitive landscape and plan their strategies. We collect our data through two main methods:
1. Primary Research: Direct interviews with industry experts and insights from top research analysts.
2. Secondary Research: Information from company annual reports and public records.
We then analyze this data using proven methods like SWOT analysis, PORTER's Five Forces model, and PESTLE analysis to ensure accuracy and reliability.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Hereditary Testing Market by Type
4.1 Hereditary Testing Market Snapshot and Growth Engine
4.2 Hereditary Testing Market Overview
4.3 Hereditary Cancer Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Hereditary Cancer Testing: Geographic Segmentation Analysis
4.4 Hereditary Non-cancer Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Hereditary Non-cancer Testing: Geographic Segmentation Analysis
Chapter 5: Hereditary Testing Market by Application
5.1 Hereditary Testing Market Snapshot and Growth Engine
5.2 Hereditary Testing Market Overview
5.3 Hospital
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hospital: Geographic Segmentation Analysis
5.4 Clinic
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Clinic: Geographic Segmentation Analysis
5.5 Laboratory
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Laboratory: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Hereditary Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 MYRIAD GENETICS INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 COOPERSURGICAL INC.
6.4 NATERA INC.
6.5 INVITAE CORPORATION
6.6 QUEST DIAGNOSTICS INCORPORATED
6.7 ILLUMINA INC.
6.8 THERMO FISHER SCIENTIFIC INC.
6.9 F. HOFFMANN-LA ROCHE LTD
6.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11 AGILENT TECHNOLOGIES INC.
6.12 CENTOGENE
6.13 TWIST BIOSCIENCE
6.14 MEDGENOME
6.15 SOPHIA GENETICS
6.16 FULGENT GENETIC INC.
Chapter 7: Global Hereditary Testing Market By Region
7.1 Overview
7.2. North America Hereditary Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Hereditary Cancer Testing
7.2.4.2 Hereditary Non-cancer Testing
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Hospital
7.2.5.2 Clinic
7.2.5.3 Laboratory
7.2.5.4 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Hereditary Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Hereditary Cancer Testing
7.3.4.2 Hereditary Non-cancer Testing
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Hospital
7.3.5.2 Clinic
7.3.5.3 Laboratory
7.3.5.4 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Hereditary Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Hereditary Cancer Testing
7.4.4.2 Hereditary Non-cancer Testing
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Hospital
7.4.5.2 Clinic
7.4.5.3 Laboratory
7.4.5.4 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Hereditary Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Hereditary Cancer Testing
7.5.4.2 Hereditary Non-cancer Testing
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Hospital
7.5.5.2 Clinic
7.5.5.3 Laboratory
7.5.5.4 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East and Africa Hereditary Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Hereditary Cancer Testing
7.6.4.2 Hereditary Non-cancer Testing
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Hospital
7.6.5.2 Clinic
7.6.5.3 Laboratory
7.6.5.4 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Hereditary Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Hereditary Cancer Testing
7.7.4.2 Hereditary Non-cancer Testing
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Hospital
7.7.5.2 Clinic
7.7.5.3 Laboratory
7.7.5.4 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Hereditary Testing Scope:
|
Report Data
|
Hereditary Testing Market
|
|
Hereditary Testing Market Size in 2025
|
USD XX million
|
|
Hereditary Testing CAGR 2025 - 2032
|
XX%
|
|
Hereditary Testing Base Year
|
2024
|
|
Hereditary Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Myriad Genetics Inc., CooperSurgical Inc., Natera Inc., Invitae Corporation, Quest Diagnostics Incorporated, Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Agilent Technologies Inc., CENTOGENE, Twist Bioscience, Medgenome, Sophia Genetics, Fulgent Genetic Inc..
|
|
Key Segments
|
By Type
Hereditary Cancer Testing
Hereditary Non-cancer Testing
By Applications
Hospital
Clinic
Laboratory
Others
|
